
Justice Purushaindra Kumar Kaurav sends back ten intellectual property suits, saying other courts are better placed.
The Delhi High Court on Thursday declined ten intellectual property suits, finding no territorial jurisdiction, Bar & Bench reports. Justice Purushaindra Kumar Kaurav returned all ten plaints to be filed in the proper courts. He said a thin link to Delhi does not justify keeping a case that sits closer to another court.
In Novartis's patent suit over the cancer drug Dabrafenib, part of the cause of action arose in Delhi, where the drug was sold. The judge held that Mumbai was closer, as Novartis's Indian affiliate, which holds the import licence, is based there. In Gebr Schmid's suit against Waaree Energies, the injunction sought would reach manufacture in Surat.
Nyra Chocolates' design suit relied on a trap order placed with a dealer in Bihar. The court treated delivery as made in Indore. Sotkon, Mold-Tek Packaging, HLE Glascoat, Plusplus Lifesciences, Global Music Junction and Dr. Reddy's Laboratories filed the other suits. A larger bench reserved its verdict on the issue less than two weeks ago.
Published under the editorial responsibility of Kelly Moon, Editor-in-Chief


